Diagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report

dc.authoridÇetin, Kenan / 0000-0002-8616-9784
dc.contributor.authorEmiroğlu, Mustafa
dc.contributor.authorAkcan, Alper
dc.contributor.authorVelidedeoğlu, Mehmet
dc.contributor.authorGirgin, Sadullah
dc.contributor.authorAytaç, Özgür
dc.contributor.authorCantürk, N. Zafer
dc.contributor.authorYılmaz, Kerim Bora
dc.contributor.authorÇetin, Kenan
dc.date.accessioned2025-01-27T21:13:48Z
dc.date.available2025-01-27T21:13:48Z
dc.date.issued2024
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective: The aim of the idiopathic granulomatous mastitis (IGM) consensus study was to evaluate the etiology, diagnostic steps, and differential diagnosis and propose a widely accepted clinical classification of this mysterious breast disease. Method: The organization of a national IGM consensus was decided by the joint evaluation of the Turkish Federation of Breast Diseases Societies, SENATURK, and the Society of Breast Surgery. First, a working group of 11 members was formed, and a survey and workshop were organized to reach a common consensus. The modified Delphi method was used in the consensus methodology. Voting rates of 80% and above were considered as acceptance. Results: The consensus was 45/50 (92%) that core needle biopsies are necessary for the diagnosis of IGM and 39/40 (97%) that a new clinical classification is needed. The proposed Turkish clinical classification of IGM was accepted by 94% in three rounds of voting. Conclusion: This disease should be considered etiologically idiopathic. Tissue diagnosis and pathological evaluation are recommended for treatment. The proposed IGM Turkey classification was strongly accepted. Idiopathic granulomatous mastitis is a highly heterogeneous group of diseases. There is ongoing controversy regarding the etiology, clinical classification, and treatment algorithm of the disease. There is no common terminological language for the clinical signs and symptoms of the disease. Treatment algorithms are diverse, and there is no standardization. Scientific comparisons cannot be made precisely due to the inclusion of heterogeneous groups in studies. Since there is no consensus on the severity of the disease, the types of treatment do not allow for comparisons between groups with the same clinical severity. These scientific limitations create difficulties in establishing national/international treatment algorithms or the acceptance of proposed algorithms. This consensus, prepared by our working group, defines a diagnostic algorithm for disease diagnosis and a terminological classification. The classification system, prepared according to disease severity, will be a pioneer in comparing patient groups and developing treatment algorithms.
dc.identifier.doi10.1159/000541482
dc.identifier.issn1661-3791
dc.identifier.issn1661-3805
dc.identifier.issue5
dc.identifier.pmid39439860
dc.identifier.scopus2-s2.0-85207346342
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1159/000541482
dc.identifier.urihttps://hdl.handle.net/20.500.12428/28525
dc.identifier.volume19
dc.identifier.wosWOS:001329230700001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherKarger
dc.relation.ispartofBreast Care
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectIdiopathic granulomatous mastitis
dc.subjectDiagnosis
dc.subjectClinical classification
dc.titleDiagnosis, Approach, and Clinical Classification of Idiopathic Granulomatous Mastitis: Consensus Report
dc.typeArticle

Dosyalar